In addition to AFFiRiS and Prothena, BioArctic Neuroscience AB continues to report earlier - stage but
promising preclinical results with their lead candidate PD0805, a mAB targeting AS protofibrils.
Not exact matches
However, VCU Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) scientists in the lab of Paul B. Fisher, M.Ph., Ph.D., are hoping to change that with a novel combination of an experimental drug and a common antibiotic that has shown
promising results in
preclinical experiments.
«Stem cell - based therapy for targeting skin - to - brain cancer: Stem cells loaded with oncolytic viruses show
promising results in
preclinical models for targeting skin cancer metastases in the brain.»
MSCs have been extensively tested in
preclinical and clinical studies, and have led to
promising results in treatment of numerous diseases.
Cell therapy has been studied for multiple degenerative disorders and
promising results from
preclinical studies and clinical trials have been described for some.
Immune checkpoint blockade has already shown
promising preclinical and clinical
results in several cancer types.
Combination of Turnstone's oncolytic viral immunotherapy with checkpoint inhibitors showed
promising results in
preclinical testing